MENU
+Compare
DXCM
Stock ticker: NASDAQ
AS OF
Apr 24 closing price
Price
$70.78
Change
+$3.92 (+5.86%)
Capitalization
53.47B

DXCM DexCom Forecast, Technical & Fundamental Analysis

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients... Show more

DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for DXCM with price predictions
Apr 24, 2025

DXCM's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for DXCM moved out of oversold territory on April 09, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 15, 2025. You may want to consider a long position or call options on DXCM as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DXCM just turned positive on April 10, 2025. Looking at past instances where DXCM's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DXCM advanced for three days, in of 314 cases, the price rose further within the following month. The odds of a continued upward trend are .

DXCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 65 cases where DXCM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for DXCM moved below the 200-day moving average on April 04, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DXCM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for DXCM entered a downward trend on April 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DXCM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (25.707) is normal, around the industry mean (23.728). P/E Ratio (106.108) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (2.565) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (16.207) is also within normal values, averaging (41.794).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DXCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DXCM is expected to report earnings to fall 27.67% to 32 cents per share on May 01

DexCom DXCM Stock Earnings Reports
Q1'25
Est.
$0.33
Q4'24
Missed
by $0.07
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.05
The last earnings report on February 13 showed earnings per share of 44 cents, missing the estimate of 51 cents. With 3.92M shares outstanding, the current market capitalization sits at 53.47B.
A.I. Advisor
published General Information

General Information

a maker of medical devices and glucose monitoring systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
6340 Sequence Drive
Phone
+1 858 200-0200
Employees
9600
Web
https://www.dexcom.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLK94.752.29
+2.48%
Westlake Corp
TNL43.740.69
+1.60%
Travel + Leisure Co
WKSP2.860.01
+0.35%
Worksport Ltd
UTL58.39-0.30
-0.51%
Unitil Corp
CRDF2.90-0.04
-1.36%
Cardiff Oncology

DXCM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
+5.86%
CERS - DXCM
42%
Loosely correlated
-0.73%
IRMD - DXCM
34%
Loosely correlated
+0.76%
ACRS - DXCM
33%
Loosely correlated
+6.72%
COO - DXCM
32%
Poorly correlated
+3.50%
BAX - DXCM
32%
Poorly correlated
+2.74%
More